Inhibiting homologous recombination for cancer therapy
Author:
Publisher
Informa UK Limited
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.4161/cbt.13.2.18872
Reference52 articles.
1. DNA repair pathways as targets for cancer therapy
2. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells
3. Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle
4. The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle
5. DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combination Therapy with Immune Checkpoint Inhibitors and Histone Deacetylase Inhibitors or Alkylating Agents;Cancer Management and Research;2024-07
2. Mild photothermal therapy boosts nanomedicine antitumor efficacy by disrupting DNA damage repair pathways and modulating tumor mechanics;Nano Today;2023-04
3. Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy/lysosomal pathway;Cell Death & Differentiation;2022-12-08
4. Junctions in DNA: underexplored targets for therapeutic intervention;Bioorganic & Medicinal Chemistry;2022-09
5. Editorial: Mechanisms guarding the genome;Frontiers in Cell and Developmental Biology;2022-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3